期刊文献+

皮下注射重组人粒细胞集落刺激因子治疗HBV相关慢加急性肝衰竭的安全性研究 被引量:7

Evaluation of the safety of granulocyte colony-stimulating factor subcutaneous injection as treatment for HBV-related acute on chronic liver failure
原文传递
导出
摘要 粒细胞集落刺激因子(G-CSF)具有促进粒系母细胞增殖和分化的作用,新近的动物实验证实G-CSF有促进肝细胞再生,改善肝组织病变,提高试验动物存活率的作用.有研究初步证实G-CSF对酒精性因素为主的慢加急性肝衰竭患者具有提高生存率、改善肝脏功能的作用[1].但上述研究未做长期随访,且我国HBV感染为肝衰竭主要诱因,因此对G-CSF治疗HBV相关慢加急性肝衰竭(HBV-ALCF)患者安全性研究具有重要临床意义.本研究采用随机对照方法,对皮下注射G-CSF治疗HBV-ACLF患者的临床资料和随访结果进行分析,以探讨其安全性.
出处 《中华肝脏病杂志》 CAS CSCD 北大核心 2015年第5期378-380,共3页 Chinese Journal of Hepatology
关键词 肝功能衰竭 粒细胞集落刺激因子 安全性 Liver failure Granulocyte colony-stimulating factor Safety
  • 相关文献

参考文献2

二级参考文献25

  • 1Liver Failure and Artificial Liver Group, Chinese Society of Infectious Diseases, Chinese Medical Association.肝衰竭诊疗指南[J].中华肝脏病杂志,2006,14(9):643-646. 被引量:829
  • 2Yao-Li Cui,Fang Yan,Yue-Bin Wang,Xue-Qin Song,Li Liu,Xue-Zhong Lei,Ming-Hua Zheng,Hong Tang,Ping Feng.Nucleoside Analogue Can Improve the Long-Term Prognosis of Patients with Hepatitis B Virus Infection-Associated Acute on Chronic Liver Failure[J]. Digestive Diseases and Sciences . 2010 (8)
  • 3Shiv Kumar Sarin,Ashish Kumar,John A. Almeida,Yogesh Kumar Chawla,Sheung Tat Fan,Hitendra Garg,H. Janaka Silva,Saeed Sadiq Hamid,Rajiv Jalan,Piyawat Komolmit,George K. Lau,Qing Liu,Kaushal Madan,Rosmawati Mohamed,Qin Ning,Salimur Rahman,Archana Rastogi,Stephen M. Riordan,Puja Sakhuja,Didier Samuel,Samir Shah,Barjesh Chander Sharma,Praveen Sharma,Yasuhiro Takikawa,Babu Ram Thapa,Chun-Tao Wai,Man-Fung Yuen.Acute-on-chronic liver failure: consensus recommendations of the Asian Pacific Association for the study of the liver (APASL)[J]. Hepatology International . 2009 (1)
  • 4Yang WB,Chen EQ,Bi HX,et al.Different models in predictingthe short-term prognosis of patients with hepatitis B virus-related a-cute-on-chronic liver failure. Annals of Hematology . 2012
  • 5Salama H,Zekri AR,Zern M,Bahnassy A,Loutfy S,Shalaby S,Vigen C,Burke W,Mostafa M,Medhat E,Alfi O,Huttinger E.Autologous hematopoietic stem celltransplantation in48patients with end-stage chronic liver diseases. Cell Transplantation . 2010
  • 6Souza BS,Nogueira RC,de Oliveira SA,de Freitas LA,Lyra LG,Ribeiro dos Santos R,Lyra AC,Soares MB.Current status of stem cell therapy for liver diseases. Cell Transplantation . 2009
  • 7Laleman W,Wilmer A,Evenepoel P,Elst IV,Zeegers M,Zaman Z,Verslype C,Fevery J,Nevens F.Effect of the molecular adsorbent recirculating system and Prometheus devices on systemic haemodynamics and vasoactive agents in patients with acute-on-chronic alcoholic liver failure. Journal of Critical Care . 2006
  • 8Tujios SR,Lee WM.New advances in chronic hepatitis B. Current Opinion in Gastroenterology . 2012
  • 9Di Campli C,Zocco MA,Saulnier N,Grieco A,Rapaccini G,Addolorato G,Rumi C,Santoliquido A,Leone G,Gas- barrini G,Gasbarrini A.Safety and efficacy profile of G-CSF therapy in patients with acute on chronic liver failure. Digestive and Liver Disease . 2007
  • 10Yannaki E,Anagnostopoulos A,Kapetanos D,Xagorari A,Iordanidis F,Batsis I,Kaloyannidis P,Athanasiou E,Dour- vas G,Kitis G,Fassas A.Lasting amelioration in the clinical course of decompensated alcoholic cirrhosis with boost infusions of mobilized peripheral blood stem cells. Exp He- matol . 2006

共引文献50

同被引文献54

引证文献7

二级引证文献34

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部